MedPath

Nutrition, Body Composition, and Sleep

Not Applicable
Completed
Conditions
Strength
Energy Expenditure
Insulin Sensitivity
Body Composition
Sleep
Interventions
Dietary Supplement: Whey protein
Dietary Supplement: Omega-3 fatty acids
Registration Number
NCT03603041
Lead Sponsor
University of Arkansas, Fayetteville
Brief Summary

The purpose of the research is to determine if protein and omega-3 fatty acid supplementation improve sleep, improve body composition, and improve markers of metabolic health in postmenopausal women.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
45
Inclusion Criteria
  • Postmenopausal women (12+ months following last reported menstrual cycle)
Exclusion Criteria
  • food allergies
  • diet restrictions
  • do not habitually eat breakfast
  • picky eaters\regularly consume protein or omega-3 related supplements
  • consume omega-3 fatty acid rich fish (tuna, salmon, etc.) greater than two times per month -have any other diet-related conditions that would prevent them from consuming whey protein supplements and/or omega-3 fatty acid supplements
  • smoking
  • habitual alcohol consumption (> 4 drinks/week)
  • medication impacting appetite or metabolism
  • Lipid or blood pressure lowering medication
  • Hormone replacement therapy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Whey Protein and Placebo Fat SourceWhey proteinParticipants will receive protein and placebo fat source supplementation daily for 16 weeks.
Whey Protein SupplementationWhey proteinParticipants will receive protein supplementation daily for 16 weeks.
Whey Protein and O3FAOmega-3 fatty acidsParticipants will receive protein and O3FA supplementation daily for 16 weeks.
Whey Protein and O3FAWhey proteinParticipants will receive protein and O3FA supplementation daily for 16 weeks.
Omega-3 Fatty Acids (O3FA)Omega-3 fatty acidsParticipants will receive O3FA supplementation daily for 16 weeks.
Primary Outcome Measures
NameTimeMethod
Sleep QualityChange in sleep quality from baseline (day 0) to 16 weeks.

Pittsburgh Sleep Quality Index (PSQI) will assess sleep quality and disturbance. This is a elf-rated questionnaire which assesses sleep quality and disturbances over a 1-month time interval. Nineteen individual items generate seven "component" scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. The sum of scores for these seven components yields one global score. Each item is weighted on a 0-3 interval scale. The global PSQI score is then calculated by totaling the seven component scores, providing an overall score ranging from 0 to 21, where lower scores denote a healthier sleep quality.

Secondary Outcome Measures
NameTimeMethod
Dietary intakeChange in dietary intake from baseline (day 0) to 16 weeks.

Dietary intake will be measured using 3-day, weighed food records.

Resting energy expenditure (REE)On day 1 and day 112 (final day of 16-week intervention) of study.

REE will be measured using indirect calorimetry.

OrexinOn day 1 and day 112 (final day of 16-week intervention) of study.

Intravenous blood samples will be collected and orexin measured using a commercial kit.

Sleep QuantityChange in sleep quantity from baseline (day 0) to 16 weeks.

Sleep duration will be measured using Actigraph monitors worn on the wrist.

Body compositionOn day 1 and day 112 (final day of 16-week intervention) of study.

Body composition will be measured using dual x-ray absorptiometry (DEXA).

Trial Locations

Locations (1)

University of Arkansas

🇺🇸

Fayetteville, Arkansas, United States

© Copyright 2025. All Rights Reserved by MedPath